| Literature DB >> 31678426 |
Thomas Eiwegger1, Katherine Anagnostou2, Stefania Arasi3, Philippe Bégin4, Moshe Ben-Shoshan5, Kirsten Beyer6, Katharina Blumchen7, Helen Brough8, Jean-Christoph Caubet9, Edmond S Chan10, Meng Chen11, Sharon Chinthrajah11, Carla M Davis2, Anne Des Roches12, George Du Toit8, Arnon Elizur13, Stephen J Galli14, Geir Håland15, Karin Hoffmann-Sommergruber16, Harold Kim17, Donald Y M Leung18, Andrew Long11, Antonella Muraro19, Ulugbek B Nurmatov20, Giovanni B Pajno21, Vanitha Sampath11, Jamie Saxena11, Sayantani Sindher11, Julia Upton22, Margitta Worm23, Kari C Nadeau24.
Abstract
Entities:
Keywords: Food allergy; Institute for Clinical and Economic Review; US Food and Drug Administration Allergenic Products Advisory Committee; efficacy; management; peanut allergy; quality of life; safety; treatment
Year: 2019 PMID: 31678426 DOI: 10.1016/j.jaci.2019.10.021
Source DB: PubMed Journal: J Allergy Clin Immunol ISSN: 0091-6749 Impact factor: 10.793